331357: REAGENT SET,BLOOD GROUPING TEST.
REAGENT SET,BLOOD GROUPING TEST. Key specifications include part_name_assigned_by_controlling_agency: BD ONCOMARK CD5/CD10/CD19. This part is cataloged in the U.S.
Government catalog under NSN 6550-01-556-0940, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| part_name_assigned_by_controlling_agency | BD ONCOMARK CD5/CD10/CD19 |
| NSN | 6550-01-556-0940 |
| SPECIAL FEATURES | BD ONCOMARK CD5 FITC/CD10 PE/CD19 PERCP-CY5.5. IS INTENDED FOR IN VITRO FLOW CYTOMETRIC IMMUNOPHENOTYPING OF NORMAL(1.2) AND ABNORMAL (3.4) B-LINEAGE DEVELOPMENT AND DIFFERENTIATION; CD10 RECOGNIZES EARLY SUBSET OF B, CD5 RECOGNIZES A PARTICULAR SUBSET WITH A MATURE PHENOTYPE; CD19 IS PRESENT DURING MOST STAGES OF B-CELL DEVELOPMENT; ANALYSIS OF THE EXPRESSION OF CD5, CD10, CD19 CAN BE USEFUL IN THE DIAGNOSIS OF B-CELL LYMPHOMAS, ACUTE LEUKEMIAS, CHRONIC LYMPHOID LEUKEMIAS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | BD ONCOMARK CD5/CD10/CD19 |
No substitute or cross-reference records for this part.